alexa
Reach Us +44-1904-929220
Non-immune Complexes Of IgG Molecules And Biomarkers | 8939
ISSN-2155-9929

Journal of Molecular Biomarkers & Diagnosis
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Non-immune complexes of IgG molecules and biomarkers

4th International Conference on Biomarkers & Clinical Research

Roald Nezlin

AcceptedAbstracts: J Mol Biomark Diagn

DOI: 10.4172/2155-9929.S1.019

Abstract
C onstant (C) parts of immunoglobulin peptide chains are composed from Ig folds or domains which belong to C1 structural variant. They have an enormous capacity to interact with various peptides and proteins through their ?hot regions?. Last decades it was found that IgG, the most abundant immunoglobulin molecules readily form complexes in a non-immune manner with a great number of protein molecules of animal, bacterial and viral origin. A variety of non-immune IgG complexes were detected in the sera of the healthy people as well in pathological sera. Among them are complexes with the participation of several disease biomarkers (for example, prostate specific protein, PSA). About half of the serum proteins have a molecular mass below 45 kDa, i.e. the kidney size cutoff. Such protein molecules cannot exist in bloodstream for long, and they are removed from the circulation more or less rapidly by glomerular filtration or proteolytic degradation. The fast elimination of many serum proteins from the circulation is an obvious obstacle for finding potential clinical biomarkers. The association of small proteins with large molecules, such as IgG, which have long half-time, could prolong their presence in the circulation as compared with their free form. Therefore the chances to discover new specific clinical biomarkers in the circulation would be significantly higher if searches encompass not only molecules that are in a free state in the bloodstream but also large abundant protein molecules with associated proteins.
Biography
Relevant Topics
Top